Skip to main content

Advertisement

Fig. 1 | Journal of Neuroinflammation

Fig. 1

From: Next-generation sequencing identifies altered whole blood microRNAs in neuromyelitis optica spectrum disorder which may permit discrimination from multiple sclerosis

Fig. 1

Synopsis of results of the serum NGS study. MiRNA expression profiles were compared in sera of 20 patients with NMOSD, 20 patients with CIS/RRMS, and 20 healthy controls. The upper part of the figure lists the 18 miRNAs with significant unadjusted p values as detected by a three-group comparison by ANOVA. The lower part lists the results of two-group comparisons between the different groups. CIS clinically isolated syndrome, RRMS relapsing-remitting multiple sclerosis, NMOSD neuromyelitis optica spectrum disorder, ANOVA analysis of variance

Back to article page